|
|
|
Volumn 17 Suppl 4, Issue , 2002, Pages 60-67
|
|
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.13 Analysis of patient and graft survival.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG DERIVATIVE;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ARTICLE;
CLINICAL TRIAL;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY TEST;
HUMAN;
KIDNEY TRANSPLANTATION;
MORTALITY;
PRACTICE GUIDELINE;
CLINICAL TRIALS;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY TESTING;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MYCOPHENOLIC ACID;
|
|
EID: 0036052221
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (39)
|
|
References (0)
|